Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits.
Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits.
CHICAGO (Reuters) – The hallucinogen psilocybin — known by the street name magic mushrooms — may help ease the anxiety that often accompanies late-stage cancer, U.S. researchers said on Monday.
LONDON (Reuters) – GlaxoSmithKline’s diabetes drug Avandia should be pulled from sale because of concerns about heart risks, British drug regulators said on Monday ahead of a special European meeting on the drug’s safety.
DHAKA (Reuters) – Bangladesh issued a red alert on Sunday over an outbreak of anthrax which has infected nearly 300 people and killed about 150 cattle in the north of the country in the past two weeks.
SILVER SPRING, Maryland (Reuters) – It wasn’t what you would call a casual get-together.
An international team of scientists has identified a promising drug candidate that represents an entirely new class of medicines to treat malaria, one of the biggest killers in the developing world.
LONDON (Reuters) – An experimental Novartis drug can clear malaria infection in mice with a single dose and scientists say it shows promise as a possible future treatment for one of the world’s major killer diseases.
CHICAGO (Reuters) – Teenagers who sleep less than eight hours a night on weeknights eat more fatty foods and snacks than those who get more than eight hours of sleep a night, U.S. researchers said on Wednesday.
The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said they were motivated by ethical objections to destroying human embryos for medical research.
Frustrated by lack of interest from drug companies, a Belgian doctor pursues own research to help cure his myasthenia gravis, a rare neurological condition.
LONDON (Reuters) – Tens of millions of people in low and middle income countries would be pushed below the poverty line by buying common but vital medicines which are already unaffordable to hundreds of millions more, a study has found.
CHICAGO (Reuters) – Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.
Genzyme CEO Henri Termeer said the French pharmaceutical company Sanofi-Aventis would have to raise its $69-a-share offer if it wants to discuss the sale of the biotechnology company.
Studies of two experimental drugs provided fuel for a race to develop medicines to replace blood thinner warfarin, a global market that could eventually exceed $20 billion a year in revenue.